برودالومب
Sign in to saveAlso known as Siliq
Brodalumab, sold under the brand name Siliq in the US and Kyntheum in the EU, is a human monoclonal antibody designed for the treatment of inflammatory diseases.
Research
739 papers- Brodalumab.2006
- Secukinumab, ixekizumab, bimekizumab and brodalumab for psoriasis and psoriatic arthritis.Drugs of today (Barcelona, Spain : 1998) · 2023
- Brodalumab.2012
- Brodalumab: A Review of Safety.Skin therapy letter · 2018
- Brodalumab for the treatment of plaque psoriasis: up-to-date.Expert opinion on biological therapy · 2019
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Has use
- medication
Show 5 more facts
- medical condition treated
- psoriasis
- World Health Organisation international non-proprietary name
- brodalumabum
- subject has role
- monoclonal antibody
- defined daily dose
- 15
- legal status (medicine)
- boxed warning
via Wikidata · CC0